Neutralizing antibodies during treatment of secondary progressive MS with interferon beta-1b.


OBJECTIVE To investigate the relationship between neutralizing antibodies (NAB) and disease progression, relapses, and MR measures of MS. METHODS Sequential serum samples from all 718 patients of the European Study Group in Interferon beta-1b in Secondary Progressive MS were analyzed to investigate relations between NAB and disease progression, relapses… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.